Enzo Total Liab vs Retained Earnings Analysis

ENZ Stock

USD 1.04 0.02 1.89%

Enzo Biochem financial indicator trend analysis is much more than just examining Enzo Biochem latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Enzo Biochem is a good investment. Please check the relationship between Enzo Biochem Total Liab and its Retained Earnings accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Enzo Biochem. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.

For more information on how to buy Enzo Stock please use our How to Invest in Enzo Biochem guide.

Total Liab vs Retained Earnings

Total Liab vs Retained Earnings Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Enzo Biochem Total Liab account and Retained Earnings. At this time, the significance of the direction appears to have weak relationship.

The correlation between Enzo Biochem's Total Liab and Retained Earnings is 0.31. Overlapping area represents the amount of variation of Total Liab that can explain the historical movement of Retained Earnings in the same time period over historical financial statements of Enzo Biochem, assuming nothing else is changed. The correlation between historical values of Enzo Biochem's Total Liab and Retained Earnings is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Liab of Enzo Biochem are associated (or correlated) with its Retained Earnings. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Retained Earnings has no effect on the direction of Total Liab i.e., Enzo Biochem's Total Liab and Retained Earnings go up and down completely randomly.

Correlation Coefficient

0.31

Relationship Direction	Positive
Relationship Strength	Very Weak

View All Relationships

Total Liab

The total amount of all liabilities that a company has, including both short-term and long-term liabilities.

Retained Earnings

The cumulative amount of net income that a company retains for reinvestment in its operations, rather than distributing it to shareholders as dividends.

Most indicators from Enzo Biochem's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Enzo Biochem current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Enzo Biochem. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.

For more information on how to buy Enzo Stock please use our How to Invest in Enzo Biochem guide.At this time, Enzo Biochem's Selling General Administrative is fairly stable compared to the past year. Discontinued Operations is likely to rise to about 54.7 M in 2024, whereas Sales General And Administrative To Revenue is likely to drop 0.59 in 2024.

	2021	2022	2023	2024 (projected)
Gross Profit	42.0M	11.6M	13.3M	12.6M
Total Revenue	107.1M	31.1M	35.7M	63.8M

Gross Profit Total Revenue

Enzo Biochem fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Intangible Assets	Accounts Payable	Short Term Debt	Common Stock Total Equity	Common Stock
Total Assets		-0.02	0.42	0.5	0.84	0.48	-0.61	-0.12	0.71	0.2	-0.11	0.79	-0.33	0.6	-0.06	0.16	0.29	0.41	0.3	0.51	0.93	-0.44	-0.16	0.09	0.6	0.62
Short Long Term Debt Total	-0.02		-0.21	-0.29	-0.46	0.4	0.54	0.63	-0.12	0.4	0.78	-0.07	-0.59	-0.53	0.98	-0.17	0.21	-0.62	0.8	0.22	-0.16	-0.44	-0.51	0.31	-0.56	-0.55
Other Current Liab	0.42	-0.21		0.85	0.31	0.28	-0.36	-0.27	0.48	0.3	-0.24	0.5	-0.5	0.33	-0.28	0.22	0.2	0.26	0.31	0.61	0.32	0.32	-0.36	0.23	0.41	0.44
Total Current Liabilities	0.5	-0.29	0.85		0.39	0.36	-0.4	-0.49	0.48	0.36	-0.48	0.5	-0.24	0.53	-0.42	0.25	0.22	0.45	0.32	0.63	0.37	0.28	-0.15	0.46	0.62	0.64
Total Stockholder Equity	0.84	-0.46	0.31	0.39		0.14	-0.81	-0.3	0.69	-0.07	-0.38	0.74	0.03	0.65	-0.46	0.11	0.12	0.53	-0.21	0.22	0.88	-0.31	0.17	-0.2	0.66	0.67
Property Plant And Equipment Net	0.48	0.4	0.28	0.36	0.14		0.31	-0.37	-0.11	0.91	-0.15	0.01	-0.17	0.46	0.26	0.68	0.87	0.38	0.62	0.8	0.14	-0.28	0.06	0.65	0.46	0.46
Net Debt	-0.61	0.54	-0.36	-0.4	-0.81	0.31		0.07	-0.87	0.48	0.22	-0.81	0.12	-0.35	0.5	0.31	0.33	-0.25	0.27	0.02	-0.79	0.06	0.11	0.32	-0.38	-0.4
Retained Earnings	-0.12	0.63	-0.27	-0.49	-0.3	-0.37	0.07		0.23	-0.36	0.94	0.22	-0.61	-0.82	0.75	-0.71	-0.45	-0.9	0.31	-0.29	0.01	-0.29	-0.69	-0.39	-0.83	-0.82
Cash	0.71	-0.12	0.48	0.48	0.69	-0.11	-0.87	0.23		-0.26	0.12	0.97	-0.52	0.13	-0.1	-0.43	-0.23	-0.05	0.17	0.21	0.81	-0.22	-0.45	-0.17	0.18	0.21
Non Current Assets Total	0.2	0.4	0.3	0.36	-0.07	0.91	0.48	-0.36	-0.26		-0.17	-0.15	-0.12	0.26	0.25	0.64	0.83	0.23	0.59	0.75	-0.16	-0.09	0.11	0.73	0.29	0.28
Non Currrent Assets Other	-0.11	0.78	-0.24	-0.48	-0.38	-0.15	0.22	0.94	0.12	-0.17		0.13	-0.68	-0.77	0.88	-0.55	-0.26	-0.86	0.49	-0.12	-0.04	-0.37	-0.75	-0.27	-0.79	-0.77
Cash And Short Term Investments	0.79	-0.07	0.5	0.5	0.74	0.01	-0.81	0.22	0.97	-0.15	0.13		-0.55	0.17	-0.05	-0.35	-0.15	-0.02	0.25	0.27	0.85	-0.33	-0.46	-0.16	0.22	0.26
Net Receivables	-0.33	-0.59	-0.5	-0.24	0.03	-0.17	0.12	-0.61	-0.52	-0.12	-0.68	-0.55		0.38	-0.59	0.34	0.08	0.52	-0.74	-0.36	-0.29	0.16	0.91	-0.07	0.35	0.31
Common Stock Shares Outstanding	0.6	-0.53	0.33	0.53	0.65	0.46	-0.35	-0.82	0.13	0.26	-0.77	0.17	0.38		-0.62	0.65	0.45	0.97	-0.18	0.4	0.51	0.0	0.47	0.24	0.99	0.99
Non Current Liabilities Total	-0.06	0.98	-0.28	-0.42	-0.46	0.26	0.5	0.75	-0.1	0.25	0.88	-0.05	-0.59	-0.62		-0.25	0.11	-0.72	0.71	0.12	-0.15	-0.46	-0.56	0.11	-0.65	-0.64
Inventory	0.16	-0.17	0.22	0.25	0.11	0.68	0.31	-0.71	-0.43	0.64	-0.55	-0.35	0.34	0.65	-0.25		0.82	0.68	0.01	0.6	-0.08	0.21	0.46	0.27	0.63	0.62
Other Current Assets	0.29	0.21	0.2	0.22	0.12	0.87	0.33	-0.45	-0.23	0.83	-0.26	-0.15	0.08	0.45	0.11	0.82		0.39	0.35	0.79	-0.02	-0.14	0.3	0.43	0.45	0.44
Other Stockholder Equity	0.41	-0.62	0.26	0.45	0.53	0.38	-0.25	-0.9	-0.05	0.23	-0.86	-0.02	0.52	0.97	-0.72	0.68	0.39		-0.33	0.27	0.33	0.15	0.6	0.26	0.95	0.94
Total Liab	0.3	0.8	0.31	0.32	-0.21	0.62	0.27	0.31	0.17	0.59	0.49	0.25	-0.74	-0.18	0.71	0.01	0.35	-0.33		0.61	0.09	-0.27	-0.62	0.55	-0.16	-0.14
Property Plant And Equipment Gross	0.51	0.22	0.61	0.63	0.22	0.8	0.02	-0.29	0.21	0.75	-0.12	0.27	-0.36	0.4	0.12	0.6	0.79	0.27	0.61		0.23	0.05	-0.19	0.44	0.44	0.46
Total Current Assets	0.93	-0.16	0.32	0.37	0.88	0.14	-0.79	0.01	0.81	-0.16	-0.04	0.85	-0.29	0.51	-0.15	-0.08	-0.02	0.33	0.09	0.23		-0.41	-0.2	-0.17	0.5	0.52
Intangible Assets	-0.44	-0.44	0.32	0.28	-0.31	-0.28	0.06	-0.29	-0.22	-0.09	-0.37	-0.33	0.16	0.0	-0.46	0.21	-0.14	0.15	-0.27	0.05	-0.41		0.04	0.05	0.02	0.03
Accounts Payable	-0.16	-0.51	-0.36	-0.15	0.17	0.06	0.11	-0.69	-0.45	0.11	-0.75	-0.46	0.91	0.47	-0.56	0.46	0.3	0.6	-0.62	-0.19	-0.2	0.04		0.1	0.44	0.4
Short Term Debt	0.09	0.31	0.23	0.46	-0.2	0.65	0.32	-0.39	-0.17	0.73	-0.27	-0.16	-0.07	0.24	0.11	0.27	0.43	0.26	0.55	0.44	-0.17	0.05	0.1		0.26	0.25
Common Stock Total Equity	0.6	-0.56	0.41	0.62	0.66	0.46	-0.38	-0.83	0.18	0.29	-0.79	0.22	0.35	0.99	-0.65	0.63	0.45	0.95	-0.16	0.44	0.5	0.02	0.44	0.26		1.0
Common Stock	0.62	-0.55	0.44	0.64	0.67	0.46	-0.4	-0.82	0.21	0.28	-0.77	0.26	0.31	0.99	-0.64	0.62	0.44	0.94	-0.14	0.46	0.52	0.03	0.4	0.25	1.0

Click cells to compare fundamentals

Enzo Biochem Account Relationship Matchups

Enzo Biochem fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	112.5M	113.7M	95.9M	121.9M	140.2M	100.7M
Short Long Term Debt Total	32.8M	22.7M	20.6M	7.0M	6.3M	6.0M
Other Current Liab	10.3M	11.6M	12.3M	21.1M	24.3M	25.5M
Total Current Liabilities	32.8M	26.1M	24.6M	40.0M	46.0M	48.3M
Total Stockholder Equity	58.4M	68.6M	54.5M	78.5M	90.2M	75.1M
Property Plant And Equipment Net	34.4M	33.6M	32.4M	16.7M	19.2M	12.3M
Net Debt	(15.1M)	9.2M	(1.0M)	(75.4M)	(67.8M)	(64.4M)
Retained Earnings	(278.3M)	(270.4M)	(288.6M)	(268.4M)	(241.5M)	(229.4M)
Cash	47.9M	13.5M	21.6M	82.4M	94.7M	99.5M
Non Current Assets Total	43.8M	43.1M	41.5M	23.4M	26.9M	32.4M
Non Currrent Assets Other	1.4M	1.8M	1.6M	1.7M	1.5M	1.5M
Cash And Short Term Investments	47.9M	43.5M	21.6M	82.4M	94.7M	99.5M
Net Receivables	9.1M	10.2M	11.5M	4.8M	5.5M	5.3M
Common Stock Shares Outstanding	47.7M	48.3M	48.6M	49.2M	56.5M	36.9M
Liabilities And Stockholders Equity	112.5M	113.7M	95.9M	121.9M	140.2M	100.7M
Non Current Liabilities Total	21.4M	19.0M	16.8M	3.4M	3.1M	2.9M
Inventory	7.8M	12.7M	15.4M	7.9M	9.1M	5.6M
Other Current Assets	4.0M	4.2M	5.8M	2.3M	2.7M	2.8M
Other Stockholder Equity	334.5M	337.1M	339.5M	344.4M	396.1M	215.7M
Total Liab	54.2M	45.1M	41.4M	43.4M	39.1M	41.0M
Property Plant And Equipment Gross	34.4M	33.6M	63.9M	34.0M	39.1M	41.0M
Total Current Assets	68.8M	70.6M	54.4M	98.5M	113.2M	68.3M
Accumulated Other Comprehensive Income	1.7M	1.4M	3.2M	1.9M	2.2M	2.3M
Intangible Assets	1.0M	538K	244K	7.5M	6.7M	6.7M
Accounts Payable	8.5M	8.1M	8.5M	3.6M	4.1M	5.0M
Short Term Debt	11.5M	3.7M	3.7M	3.6M	3.2M	3.5M
Common Stock Total Equity	476K	479K	485K	487K	560.1K	422.6K
Common Stock	479K	485K	487K	499K	573.9K	427.7K
Other Assets	1.4M	1.8M	1.6M	6.7M	6.0M	6.3M
Property Plant Equipment	14.5M	33.6M	17.3M	16.7M	19.2M	10.2M
Current Deferred Revenue	(391K)	2.5M	2.7M	11.7M	13.5M	14.2M
Long Term Debt	4.5M	4.4M	4.1M	269K	309.4K	293.9K
Net Tangible Assets	50.4M	60.9M	47.0M	78.5M	90.2M	58.6M
Retained Earnings Total Equity	(252.2M)	(249.7M)	(278.3M)	(288.6M)	(259.8M)	(272.8M)
Capital Surpluse	334.5M	337.1M	339.5M	344.4M	396.1M	359.7M
Non Current Liabilities Other	424K	16.9M	5K	12.8M	14.7M	15.4M
Short Long Term Debt	7.1M	152K	229K	2.6M	2.3M	1.5M

Pair Trading with Enzo Biochem

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Enzo Biochem position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Enzo Biochem will appreciate offsetting losses from the drop in the long position's value.

Moving together with Enzo Stock

0.61

Guardant Health Financial Report 14th of May 2024

Pair Corr

Moving against Enzo Stock

0.86	INSP	Inspire Medical Systems Financial Report 7th of May 2024	Pair Corr
0.76	BSX	Boston Scientific Corp	Pair Corr
0.73	EHC	Encompass Health Corp	Pair Corr
0.62	GKOS	Glaukos Corp	Pair Corr
0.44	DXCM	DexCom Inc	Pair Corr

The ability to find closely correlated positions to Enzo Biochem could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Enzo Biochem when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Enzo Biochem - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Enzo Biochem to buy it.

The correlation of Enzo Biochem is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Enzo Biochem moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Enzo Biochem moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Enzo Biochem can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Enzo Biochem offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Enzo Biochem's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Enzo Biochem Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Enzo Biochem Stock:

How To Invest In Enzo

Details

Is Enzo Stock a good investment?

Details

What is Enzo Biochem's Net Worth?

Details

Largest Health Care Providers & Services Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Enzo Biochem. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.

For more information on how to buy Enzo Stock please use our How to Invest in Enzo Biochem guide.

You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.

Complementary Tools for Enzo Stock analysis

When running Enzo Biochem's price analysis, check to measure Enzo Biochem's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Enzo Biochem is operating at the current time. Most of Enzo Biochem's value examination focuses on studying past and present price action to predict the probability of Enzo Biochem's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Enzo Biochem's price. Additionally, you may evaluate how the addition of Enzo Biochem to your portfolios can decrease your overall portfolio volatility.

	Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
	Risk-Return Analysis View associations between returns expected from investment and the risk you assume
	Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
	AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities
	Insider Screener Find insiders across different sectors to evaluate their impact on performance
	Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated
	Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges
	Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences
	Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
	Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities
	Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities
	ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
	Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes

Is Enzo Biochem's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Enzo Biochem. If investors know Enzo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Enzo Biochem listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(0.47)

Revenue Per Share

0.657

Quarterly Revenue Growth

0.138

Return On Assets

(0.17)

Return On Equity

(0.45)

The market value of Enzo Biochem is measured differently than its book value, which is the value of Enzo that is recorded on the company's balance sheet. Investors also form their own opinion of Enzo Biochem's value that differs from its market value or its book value, called intrinsic value, which is Enzo Biochem's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Enzo Biochem's market value can be influenced by many factors that don't directly affect Enzo Biochem's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Enzo Biochem's value and its price as these two are different measures arrived at by different means. Investors typically determine if Enzo Biochem is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Enzo Biochem's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Enzo Total Liab vs Retained Earnings Analysis

Total Liab vs Retained Earnings

Total Liab vs Retained Earnings Correlation Analysis

Correlation Coefficient

Total Liab

Retained Earnings

Enzo Biochem fundamental ratios Correlations

Enzo Biochem Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Enzo Biochem fundamental ratios Accounts

Pair Trading with Enzo Biochem

Moving together with Enzo Stock

Moving against Enzo Stock

Complementary Tools for Enzo Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Common Stock	+ 1.0	Common Stock Total Equity
Common Stock Total Equity	+ 0.99	Common Stock Shares Outstanding
Common Stock	+ 0.99	Common Stock Shares Outstanding
Non Current Liabilities Total	+ 0.98	Short Long Term Debt Total
Cash And Short Term Investments	+ 0.97	Cash
Other Stockholder Equity	+ 0.97	Common Stock Shares Outstanding

Other Stockholder Equity	- 0.9	Retained Earnings
Cash	- 0.87	Net Debt
Other Stockholder Equity	- 0.86	Non Currrent Assets Other
Common Stock Total Equity	- 0.83	Retained Earnings
Common Stock	- 0.82	Retained Earnings
Common Stock Shares Outstanding	- 0.82	Retained Earnings